Tuesday, Apr 5, 2022 | 1:00 PM ET
The CROs role in Driving Scientific Innovation for Better Patient Outcomes
From the initial U.S. emergence of the coronavirus in early 2020, contract research organizations, or CROs, have been at the forefront of collaborating with pharmaceutical, biotech and medical device companies to develop innovative new medicines, treatments and equipment that improve patient outcomes.
Partnerships are more important than ever to help CROs as they navigate ongoing industry disruptions and uncertainty, supporting an enduring focus on key industry imperatives to accelerate scientific innovation, build operational agility, drive digital transformation and deliver a positive employee and patient experience.
Join leading experts to dive into:
- The evolving role of CROs in supporting pharmaceutical, biotech and medical equipment companies to expedite new life-saving medicines, treatments and devices
- How to navigate the stringent regulatory requirements impacting CROs
- Why CROs are turning to the cloud to reimagine the clinical trial process
- How the transition from physical worksites to remote work models for both employees and patients is improving patient experiences
Dave MeyersNational Director Life Sciences, US Health & Life Sciences, Microsoft
Adam MarianoVice President, Health Innovation, IQVIA
Kate LiebeltDirector & People Leader, Business Operations and Strategy, Pharmacovigilance and Patient Safety, AbbVie